About CRISPR QC
CRISPR QC is a company based in San Diego (United States) founded in 2021 by Ross Bundy.. CRISPR QC has raised $12.49 million across 4 funding rounds from investors including Xcellerant Ventures, Serra Ventures and EvoNexus. CRISPR QC offers products and services including CRISPR Analytics Platform™, RNP Formation Insight, DNA Target Binding Insight, and CLEAVE Insight. CRISPR QC operates in a competitive market with competitors including Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.
- Headquarter San Diego, United States
- Founders Ross Bundy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Crispr Qc™, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.49 M (USD)
in 4 rounds
-
Latest Funding Round
$10 M (USD), Series A
Jan 02, 2024
-
Investors
Xcellerant Ventures
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CRISPR QC
CRISPR QC offers a comprehensive portfolio of products and services, including CRISPR Analytics Platform™, RNP Formation Insight, DNA Target Binding Insight, and CLEAVE Insight. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Measures real-time kinetics for CRISPR gene editing optimization.
Analyzes nucleic acid-protein interactions for efficient gRNA screening.
Quantifies RNP binding to target DNA in real-time.
Detects CRISPR-Cas cleavage activity for improved gene editing.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of CRISPR QC
CRISPR QC has successfully raised a total of $12.49M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $10.0M
-
First Round
First Round
(21 Mar 2022)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series A - CRISPR QC | Valuation | Xcellerant Ventures |
|
| Jan, 2023 | Amount | Seed - CRISPR QC | Valuation | Serra Ventures |
|
| Aug, 2022 | Amount | Seed - CRISPR QC | Valuation | EvoNexus |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CRISPR QC
CRISPR QC has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Xcellerant Ventures, Serra Ventures and EvoNexus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Xcellerant Ventures is focused on funding healthcare innovation.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on Agtech and multiple sectors
|
Founded Year | Domain | Location | |
|
12-18 month incubation programs are provided for startups in California.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CRISPR QC
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CRISPR QC
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Crispr Qc Comparisons
Competitors of CRISPR QC
CRISPR QC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| domain | founded_year | HQ Location |
Genetic therapies for diseases are developed using prime editing technology.
|
|
| domain | founded_year | HQ Location |
A CRISPR-based gene-editing platform is developed for therapeutic applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Crispr Qc
Frequently Asked Questions about CRISPR QC
When was CRISPR QC founded?
CRISPR QC was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is CRISPR QC located?
CRISPR QC is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of CRISPR QC?
Ross Bundy is the current CEO of CRISPR QC. They have also founded this company.
Is CRISPR QC a funded company?
CRISPR QC is a funded company, having raised a total of $12.49M across 4 funding rounds to date.
What does CRISPR QC do?
Founded in 2021 and based in San Diego, United States, CRISPR QC operates in the biotechnology sector. Real-time analysis platforms for CRISPR gene editing are developed, including measurements of RNP formation, DNA target binding, and cleavage activity. These services facilitate gRNA design optimization and workflow efficiency enhancements. Data-driven insights are supplied to identify issues early, thereby minimizing troubleshooting and supporting resource allocation in gene editing research.
Who are the top competitors of CRISPR QC?
CRISPR QC's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.
What products or services does CRISPR QC offer?
CRISPR QC offers CRISPR Analytics Platform™, RNP Formation Insight, DNA Target Binding Insight, and CLEAVE Insight.
Who are CRISPR QC's investors?
CRISPR QC has 3 investors. Key investors include Xcellerant Ventures, Serra Ventures, and EvoNexus.